Latest / Decera Clinical Education Oncology Podcast
Immunotherapy in SCLC: FAQ on Current Best Practice and Emerging Therapeutic Strategies
In this episode, Anna F. Farago, MD, PhD, and Taofeek K. Owonikoko, MD, PhD, answer questions focused on the topic of current and evolving use of immunotherapy in patients with advanced small-cell lung cancer with topics including:
Selecting between atezolizumab and durvalumab in the frontline setting
Integration of lurbinectedin, a novel anticancer drug that was recently approved for the treatment of relapsed SCLC after platinum-based chemotherapy, into patient care
Which patients should receive salvage therapy with an immune checkpoint inhibitor in the third-line setting
Management of brain…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.